Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromelain for pain after orthodontic separator placement
IRCT20241214064046N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules, Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of bromelain, ibuprofen and Placebo-COD Research Private Ltd in pain (3 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Level of pain after separator placement. Started May 2025; status: completed.
02
Drugs
bromelainibuprofenPlacebo-COD Research Private Ltd
03
Conditions
pain
Beyond the preview
Go deeper on IRCT20241214064046N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241214064046N1.